Serial Number 76977972
Registration 3115884
800

Registration Progress

Application Filed
Jan 12, 2005
Under Examination
Approved for Publication
Apr 5, 2006
Published for Opposition
Apr 25, 2006
Registered
Jul 18, 2006

Trademark Image

Basic Information

Serial Number
76977972
Registration Number
3115884
Filing Date
January 12, 2005
Registration Date
July 18, 2006
Published for Opposition
April 25, 2006
Renewal Date
July 18, 2016
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
800
Status Date
Sep 1, 2015
Registration
Registered
Classes
005

Rights Holder

Synta Pharmaceuticals Corp.

03
Address
45 Hartwell Avenue
Lexington, MA 02421

Ownership History

Synta Pharmaceuticals Corp.

Original Applicant
03
Lexington, MA

Synta Pharmaceuticals Corp.

Owner at Publication
03
Lexington, MA

Synta Pharmaceuticals Corp.

Original Registrant
03
Lexington, MA

Legal Representation

Attorney
Roberta Jacobs-Meadway

USPTO Deadlines

Next Deadline
370 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-07-18)
Due Date
July 18, 2026
Grace Period Ends
January 18, 2027

Application History

32 events
Date Code Type Description
Jun 2, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 1, 2015 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 1, 2015 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 1, 2015 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 4, 2015 E89R I TEAS SECTION 8 & 9 RECEIVED
Jul 18, 2015 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 26, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2012 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 11, 2012 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 19, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 16, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 13, 2012 E815 I TEAS SECTION 8 & 15 RECEIVED
Mar 26, 2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 18, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 25, 2006 PUBO A PUBLISHED FOR OPPOSITION
Apr 5, 2006 NPUB O NOTICE OF PUBLICATION
Mar 7, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 24, 2006 ALIE A ASSIGNED TO LIE
Feb 17, 2006 IUAA P USE AMENDMENT ACCEPTED
Feb 17, 2006 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2006 AUPC I AMENDMENT TO USE PROCESSING COMPLETE
Feb 14, 2006 MNDA O NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
Feb 10, 2006 DPCC D DIVISIONAL PROCESSING COMPLETE
Feb 9, 2006 FAXX I FAX RECEIVED
Jan 31, 2006 MAIL I PAPER RECEIVED
Jan 31, 2006 DRRR I DIVISIONAL REQUEST RECEIVED
Jan 31, 2006 IUAF S USE AMENDMENT FILED
Aug 17, 2005 CNRT F NON-FINAL ACTION MAILED
Aug 16, 2005 CNRT R NON-FINAL ACTION WRITTEN
Aug 12, 2005 DOCK D ASSIGNED TO EXAMINER
Jan 26, 2005 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
PHARMACEUTICAL PRODUCTS, NAMELY, DRUGS FOR INFLAMMATORY DISEASES, AND CANCER
First Use Anywhere: Apr 11, 2005
First Use in Commerce: Apr 11, 2005

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...